HEADER ANTIMICROBIAL PROTEIN 30-JUN-05 2A4W TITLE CRYSTAL STRUCTURE OF MITOMYCIN C-BINDING PROTEIN COMPLEXED WITH TITLE 2 COPPER(II)-BLEOMYCIN A2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOMYCIN-BINDING PROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STREPTOMYCES CAESPITOSUS; SOURCE 3 ORGANISM_TAXID: 53502; SOURCE 4 GENE: MRD; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)PLYSS; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET-MRD KEYWDS ALFA/BETA PROTEIN, MITOMYCIN C-BINDING PROTEIN, COPPER(II)-BLEOMYCIN KEYWDS 2 A2, STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN KEYWDS 3 STRUCTURAL AND FUNCTIONAL ANALYSES, ANTIMICROBIAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR N.DANSHIITSOODOL,C.A.DE PINHO,Y.MATOBA,T.KUMAGAI,M.SUGIYAMA REVDAT 4 25-OCT-23 2A4W 1 REMARK LINK REVDAT 3 12-MAY-09 2A4W 1 REMARK SEQADV REVDAT 2 24-FEB-09 2A4W 1 VERSN REVDAT 1 18-JUL-06 2A4W 0 JRNL AUTH N.DANSHIITSOODOL,C.A.DE PINHO,Y.MATOBA,T.KUMAGAI,M.SUGIYAMA JRNL TITL THE MITOMYCIN C (MMC)-BINDING PROTEIN FROM MMC-PRODUCING JRNL TITL 2 MICROORGANISMS PROTECTS FROM THE LETHAL EFFECT OF BLEOMYCIN: JRNL TITL 3 CRYSTALLOGRAPHIC ANALYSIS TO ELUCIDATE THE BINDING MODE OF JRNL TITL 4 THE ANTIBIOTIC TO THE PROTEIN JRNL REF J.MOL.BIOL. V. 360 398 2006 JRNL REFN ISSN 0022-2836 JRNL PMID 16756991 JRNL DOI 10.1016/J.JMB.2006.05.017 REMARK 2 REMARK 2 RESOLUTION. 1.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.851 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 10000000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0010 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.0 REMARK 3 NUMBER OF REFLECTIONS : 38513 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.205 REMARK 3 FREE R VALUE : 0.244 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1935 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.59 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 92.80 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 5901 REMARK 3 BIN R VALUE (WORKING SET) : 0.3520 REMARK 3 BIN FREE R VALUE : 0.3370 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.70 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 290 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.020 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2021 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 97 REMARK 3 SOLVENT ATOMS : 346 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 16.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 15.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.17 REMARK 3 ESD FROM SIGMAA (A) : 0.20 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.20 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.20 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 2.600 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 26.20 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.730 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.110 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.740 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.040 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.170 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : BLEO-5.PARAM REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : TOPHCSDX.PRO.TOP REMARK 3 TOPOLOGY FILE 2 : TOPH19.SOL REMARK 3 TOPOLOGY FILE 3 : BLEO-4.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2A4W COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 01-JUL-05. REMARK 100 THE DEPOSITION ID IS D_1000033491. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-MAY-03 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : CRYSTALCLEAR REMARK 200 DATA SCALING SOFTWARE : CRYSTALCLEAR REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40048 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.500 REMARK 200 RESOLUTION RANGE LOW (A) : 26.380 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 2.860 REMARK 200 R MERGE (I) : 0.04600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.55 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 2.71 REMARK 200 R MERGE FOR SHELL (I) : 0.32300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1KLL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.46 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.07 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG8000, MES, PH 6.0, VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 30.33500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4940 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12730 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -43.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 PRO A 130 REMARK 465 LEU A 131 REMARK 465 GLU A 132 REMARK 465 HIS A 133 REMARK 465 HIS A 134 REMARK 465 HIS A 135 REMARK 465 HIS A 136 REMARK 465 HIS A 137 REMARK 465 HIS A 138 REMARK 465 MET B 201 REMARK 465 GLU B 332 REMARK 465 HIS B 333 REMARK 465 HIS B 334 REMARK 465 HIS B 335 REMARK 465 HIS B 336 REMARK 465 HIS B 337 REMARK 465 HIS B 338 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 43 -167.30 -106.03 REMARK 500 LEU B 243 -169.96 -100.42 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CU A 751 CU REMARK 620 N RES CSSEQI ATOM REMARK 620 1 BLM A 750 NB REMARK 620 2 BLM A 750 NC 81.1 REMARK 620 3 BLM A 750 NG 107.3 80.2 REMARK 620 4 BLM A 750 NH 97.3 158.1 79.6 REMARK 620 5 BLM A 750 NJ 104.4 112.1 147.5 89.5 REMARK 620 N 1 2 3 4 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CU A 751 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BLM A 750 REMARK 999 REMARK 999 SEQUENCE REMARK 999 A SEQUENCE DATABASE REFERENCE FOR THIS PROTEIN REMARK 999 WHICH DERIVES FROM STREPTOMYCES CAESPITOSUS REMARK 999 DOES NOT CURRENTLY EXIST. REMARK 999 THE 8 C-TERMINAL RESIDUES WERE HIS TAGS. DBREF 2A4W A 1 138 PDB 2A4W 2A4W 1 138 DBREF 2A4W B 201 338 PDB 2A4W 2A4W 201 338 SEQRES 1 A 138 MET SER ALA ARG ILE SER LEU PHE ALA VAL VAL VAL GLU SEQRES 2 A 138 ASP MET ALA LYS SER LEU GLU PHE TYR ARG LYS LEU GLY SEQRES 3 A 138 VAL GLU ILE PRO ALA GLU ALA ASP SER ALA PRO HIS THR SEQRES 4 A 138 GLU ALA VAL LEU ASP GLY GLY ILE ARG LEU ALA TRP ASP SEQRES 5 A 138 THR VAL GLU THR VAL ARG SER TYR ASP PRO GLU TRP GLN SEQRES 6 A 138 ALA PRO THR GLY GLY HIS ARG PHE ALA ILE ALA PHE GLU SEQRES 7 A 138 PHE PRO ASP THR ALA SER VAL ASP LYS LYS TYR ALA GLU SEQRES 8 A 138 LEU VAL ASP ALA GLY TYR GLU GLY HIS LEU LYS PRO TRP SEQRES 9 A 138 ASN ALA VAL TRP GLY GLN ARG TYR ALA ILE VAL LYS ASP SEQRES 10 A 138 PRO ASP GLY ASN VAL VAL ASP LEU PHE ALA PRO LEU PRO SEQRES 11 A 138 LEU GLU HIS HIS HIS HIS HIS HIS SEQRES 1 B 138 MET SER ALA ARG ILE SER LEU PHE ALA VAL VAL VAL GLU SEQRES 2 B 138 ASP MET ALA LYS SER LEU GLU PHE TYR ARG LYS LEU GLY SEQRES 3 B 138 VAL GLU ILE PRO ALA GLU ALA ASP SER ALA PRO HIS THR SEQRES 4 B 138 GLU ALA VAL LEU ASP GLY GLY ILE ARG LEU ALA TRP ASP SEQRES 5 B 138 THR VAL GLU THR VAL ARG SER TYR ASP PRO GLU TRP GLN SEQRES 6 B 138 ALA PRO THR GLY GLY HIS ARG PHE ALA ILE ALA PHE GLU SEQRES 7 B 138 PHE PRO ASP THR ALA SER VAL ASP LYS LYS TYR ALA GLU SEQRES 8 B 138 LEU VAL ASP ALA GLY TYR GLU GLY HIS LEU LYS PRO TRP SEQRES 9 B 138 ASN ALA VAL TRP GLY GLN ARG TYR ALA ILE VAL LYS ASP SEQRES 10 B 138 PRO ASP GLY ASN VAL VAL ASP LEU PHE ALA PRO LEU PRO SEQRES 11 B 138 LEU GLU HIS HIS HIS HIS HIS HIS HET CU A 751 1 HET BLM A 750 96 HETNAM CU COPPER (II) ION HETNAM BLM BLEOMYCIN A2 HETSYN BLM N1-[3-(DIMETHYLSULFONIO)-PROPYL]BLEOMYCINAMIDE FORMUL 3 CU CU 2+ FORMUL 4 BLM C55 H85 N17 O21 S3 FORMUL 5 HOH *346(H2 O) HELIX 1 1 ASP A 14 LYS A 24 1 11 HELIX 2 2 PRO A 30 ALA A 36 5 7 HELIX 3 3 ASP A 44 GLY A 46 5 3 HELIX 4 4 VAL A 54 SER A 59 1 6 HELIX 5 5 ASP A 81 ALA A 95 1 15 HELIX 6 6 ASP B 214 LYS B 224 1 11 HELIX 7 7 PRO B 230 ALA B 236 5 7 HELIX 8 8 ASP B 244 GLY B 246 5 3 HELIX 9 9 VAL B 254 ARG B 258 1 5 HELIX 10 10 ASP B 281 ALA B 295 1 15 SHEET 1 A 7 HIS A 38 VAL A 42 0 SHEET 2 A 7 ARG A 48 THR A 53 -1 O LEU A 49 N ALA A 41 SHEET 3 A 7 ARG A 4 VAL A 12 1 N VAL A 12 O ASP A 52 SHEET 4 A 7 PHE B 273 GLU B 278 -1 O GLU B 278 N ARG A 4 SHEET 5 A 7 VAL B 322 PRO B 328 1 O ASP B 324 N PHE B 277 SHEET 6 A 7 GLN B 310 LYS B 316 -1 N VAL B 315 O VAL B 323 SHEET 7 A 7 GLU B 298 ALA B 306 -1 N TRP B 304 O TYR B 312 SHEET 1 B 7 GLY A 99 ASN A 105 0 SHEET 2 B 7 GLN A 110 LYS A 116 -1 O TYR A 112 N TRP A 104 SHEET 3 B 7 VAL A 122 PRO A 128 -1 O VAL A 123 N VAL A 115 SHEET 4 B 7 PHE A 73 GLU A 78 1 N PHE A 77 O ASP A 124 SHEET 5 B 7 ARG B 204 VAL B 212 -1 O ARG B 204 N GLU A 78 SHEET 6 B 7 ARG B 248 THR B 253 1 O ALA B 250 N PHE B 208 SHEET 7 B 7 HIS B 238 VAL B 242 -1 N ALA B 241 O LEU B 249 LINK NB BLM A 750 CU CU A 751 1555 1555 2.29 LINK NC BLM A 750 CU CU A 751 1555 1555 2.21 LINK NG BLM A 750 CU CU A 751 1555 1555 1.92 LINK NH BLM A 750 CU CU A 751 1555 1555 2.05 LINK NJ BLM A 750 CU CU A 751 1555 1555 1.94 SITE 1 AC1 1 BLM A 750 SITE 1 AC2 26 HIS A 38 GLU A 40 SER A 59 VAL A 107 SITE 2 AC2 26 TRP A 108 GLY A 109 TYR A 112 HOH A 420 SITE 3 AC2 26 HOH A 463 HOH A 519 HOH A 538 HOH A 589 SITE 4 AC2 26 HOH A 619 HOH A 620 HOH A 653 HOH A 654 SITE 5 AC2 26 HOH A 667 HOH A 687 HOH A 693 CU A 751 SITE 6 AC2 26 HIS B 238 ASP B 252 TYR B 260 VAL B 307 SITE 7 AC2 26 TRP B 308 HOH B 576 CRYST1 44.390 60.670 48.240 90.00 101.33 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022528 0.000000 0.004514 0.00000 SCALE2 0.000000 0.016483 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021142 0.00000